F-star Therapeutics, Inc. Quarterly Costs and Expenses in USD from Q1 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
F-star Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2015 to Q3 2022.
  • F-star Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2022 was $14.8M, a 43.3% increase year-over-year.
  • F-star Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2022 was $57.9M, a 21.1% increase year-over-year.
  • F-star Therapeutics, Inc. annual Costs and Expenses for 2021 was $51.9M, a 54.2% increase from 2020.
  • F-star Therapeutics, Inc. annual Costs and Expenses for 2020 was $33.6M, a 33.8% decline from 2019.
  • F-star Therapeutics, Inc. annual Costs and Expenses for 2019 was $50.8M, a 78.5% increase from 2018.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $57.9M $14.8M +$4.48M +43.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $53.4M $16.2M +$1.39M +9.39% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $52.1M $13.7M +$178K +1.31% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $51.9M $13.2M +$4.04M +44.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $47.8M $10.4M -$2.23M -17.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $50.1M $14.8M +$9.46M +178% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $40.6M $13.6M +$6.97M +106% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $33.6M $9.14M -$16.1M -63.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $49.7M $12.6M +$5.11M +68.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $44.6M $5.33M -$4.44M -45.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $49M $6.59M -$1.79M -21.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $50.8M $25.2M +$18.6M +282% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $32.2M $7.48M -$240K -3.11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $32.5M $9.77M +$1.81M +22.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $30.6M $8.38M +$2.18M +35.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $28.5M $6.6M +$311K +4.94% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $28.2M $7.72M +$2.53M +48.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $25.6M $7.95M +$2.69M +51.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $22.9M $6.2M +$1.69M +37.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $21.3M $6.29M +$1.92M +43.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-11
Q3 2017 $19.3M $5.19M +$1.01M +24.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-25
Q2 2017 $18.3M $5.26M +$866K +19.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $17.5M $4.51M -$2.3M -33.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $19.8M $4.37M +$304K +7.47% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-20
Q3 2016 $19.5M $4.18M +$508K +13.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $18.9M $4.39M +$1.8M +69.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-31
Q1 2016 $17.1M $6.82M +$4.61M +209% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $12.5M $4.07M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-14
Q3 2015 $3.67M Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $2.6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $2.21M Jan 1, 2015 Mar 31, 2015 10-Q 2016-06-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.